COTY Reports Worsening Net Loss, $362.8M Impairment in Consumer Beauty, and New Shareholder Lawsuits
Summary
Coty Inc. reported a significant increase in net loss for Q3 and 9M fiscal 2026, driven by $362.8 million in asset impairment charges within its Consumer Beauty segment, alongside new shareholder litigation and a negative Q4 outlook.
Key Events
-
Worsening Net Loss
Net loss attributable to Coty Inc. increased to $(408.1) million for the three months ended March 31, 2026, compared to $(405.7) million in the prior year. For the nine-month period, net loss widened to $(463.8) million from $(299.1) million.
-
Major Asset Impairment
The company recorded $362.8 million in asset impairment charges during the quarter, including $237.1 million in goodwill and $125.7 million in indefinite-lived intangible assets, primarily within the Consumer Beauty segment (CoverGirl, Sally Hansen, Max Factor, and Bourjois trademarks).
-
Wella Equity Sale Completed
Coty completed the sale of its remaining 25.8% equity interest in Wella for $750.0 million in cash, recognizing a $201.9 million loss on the sale.
-
Debt Reduction
Long-term debt, net, decreased from $3,955.5 million as of June 30, 2025, to $3,169.4 million as of March 31, 2026, partially due to the issuance of $900.0 million in new senior notes and proceeds from the Wella sale used for redemptions.
Analysis
Coty's latest 10-Q reveals a challenging financial period marked by a substantial $362.8 million in asset impairment charges, primarily affecting goodwill and trademarks in its Consumer Beauty segment. This indicates significant underperformance and a re-evaluation of asset values in key brands like CoverGirl and Sally Hansen. The company's net loss widened for both the quarter and the nine-month period, reflecting these impairments and broader revenue declines in its core beauty categories. While the sale of its remaining Wella equity generated $750.0 million in cash and contributed to debt reduction, this transaction also resulted in a $201.9 million loss. The filing also highlights increasing legal risks, with new shareholder class action and derivative lawsuits alleging misleading earnings guidance, in addition to ongoing talc litigation and significant Brazilian tax assessments. The negative Q4 revenue outlook and continued gross margin pressure suggest ongoing operational headwinds. Investors should be concerned about the persistent losses, the severity of the asset write-downs, and the escalating legal challenges, which collectively point to a difficult path ahead for the company.
At the time of this filing, COTY was trading at $2.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $1.95 to $5.34. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.